Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > RATbar the liar

<< Previous

Bullboard Posts

Next >>

Comment by Rarbar99on Sep 30, 2021 10:20am

65 Views

Post# 33943135

RE:RATbar the liar

Inthepez wrote: And there you have it folks, he’s rather show us a pic of daddy’s car than his shares lmao. Classic.

No asked for “your” car baby boy. Show us the shares or stfu. Lmao!!

you are the one who was exposed. I literally showed proof that you lied about buying cheap shares. You only started investing in ate back in February 2020, you were too stupid to remember you made a post about it.

so now you either have to admit you were lying, or show us your proof. Which is it?

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing